Hypromellose Thea

Hypromellose, the active ingredient in Hypromellose Thea, is an ophthalmic lubricant presented as a sterile ophthalmic solution for ocular use. It forms a protective film on the eye surface to relieve dryness and irritation in patients with dry eye syndrome or other ocular surface disorders.

GNH USA supplies Hypromellose Thea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hypromellose Thea is an ophthalmic lubricant that addresses conditions affecting the ocular surface. - Dry eye syndrome: provides long‑lasting moisture and reduces friction to improve comfort. - Ocular surface irritation: creates a soothing film that alleviates redness and burning. - General eye lubrication: supports tear film stability for patients using contact lenses or exposed to dry environments.

Adverse reactions are generally mild but should be monitored.

Common Side Effects: - Transient blurred vision after instillation. - Mild eye irritation or burning sensation. - Redness of the conjunctiva. - Excessive tearing or watery discharge. - Foreign‑body sensation. - Itching around the eye.

Serious or Rare Side Effects: - Allergic reaction with swelling or rash. - Severe eye pain or photophobia. - Corneal ulcer or infection. - Sudden loss of vision. - Persistent inflammation requiring medical attention. - Hypersensitivity leading to conjunctival edema.

Before using Hypromellose Thea, consider the following precautions. - Avoid contamination: use only single‑dose containers and discard after opening. - Do not use if the solution appears discolored or contains particles. - Contact lens wearers: remove lenses before instillation and wait several minutes before reinserting. - If symptoms persist for more than a week, seek evaluation from an eye‑care professional. - Store at room temperature: keep in the original container, protect from light and moisture.

Hypromellose Thea may interact with other ophthalmic products.

Major Interactions (Avoid): - Concurrent use with ophthalmic anesthetics: may increase corneal toxicity. - Simultaneous administration with intra‑ocular injections: could dilute the injected medication.

Moderate Interactions (Monitor Closely): - Use with topical antibiotics: monitor for reduced antibacterial efficacy. - Combination with anti‑inflammatory eye drops: assess for additive irritation. - Co‑administration with other lubricating agents: evaluate for excessive film buildup.